Survey Closed

Gilenya, or Fingolimod, is the first approved oral disease modifying drug for MS.
Post Reply
CaseyStratisGRP
Newbie
Posts: 1
Joined: Wed Mar 22, 2017 7:57 am

Survey Closed

Post by CaseyStratisGRP » Wed Mar 22, 2017 8:27 am

Thank you for your input! We truly appreciate your time and your feedback.
Last edited by CaseyStratisGRP on Sun Mar 26, 2017 7:25 am, edited 2 times in total.

User avatar
NHE
Volunteer Moderator
Posts: 5290
Joined: Sat Nov 20, 2004 3:00 pm
Contact:

Re: Anyone on GILENYA? paid survey

Post by NHE » Thu Mar 23, 2017 5:55 am

Stratis Group wrote: About Our Company

The biopharmaceutical landscape is constantly evolving and casting new light on how manufacturers must think about and manage their portfolio.

At Stratis Group, we bring together a long history of developing and delivering focused strategy for clients, with engagement targets ranging from some of the largest and most complicated brands to early-stage portfolios.

Our team has decades of experience in the pharmaceutical industry, with a foundation in both industry and consulting. Every individual brings a range of cross-functional experience across managed care, academic research, finance, public health, and hospital administration.

While becoming a part of our clients’ teams, we thrive on solving complex brand challenges that require both deep experience and innovative thinking.

Post Reply
  • Similar Topics
    Replies
    Views
    Last post